Optimal approach to sporadic desmoid tumors: From radical surgery to observation. Time for a consensus?

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 3995-3997

  Gronchi, Alessandro ^a   Raut, Chandrajit P ^b,c,d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ABDOMINAL FIBROMATOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL OBSERVATION; CONSENSUS; DESMOID TUMOR; DESMOID TYPE FIBROMATOSIS; FIBROMATOSIS; HUMAN; MORBIDITY; MUTATION; RADICAL RESECTION; RECURRENCE FREE SURVIVAL; REVIEW; SALVAGE THERAPY; SPORADIC DESMOID TUMOR; TUMOR LOCALIZATION;

FEMALE; FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS;

EID: 84876462324     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2636-4     Document Type: Review

References (13)

1. Mullen JT, DeLaney TF, Kobayashi WK, et al. Desmoid Tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol. doi:10.1245/s10434-012-2638-2.
2. Peng PD, HyDer O, Turley R, Groeschl R, Firoozmand A, Lidsky M, et al. Management and recurrent patterns of desmoid tumors: a multiinstitutional analysis of 211 patients. Ann Surg Oncol. doi: 10.1245/s10434-012-2634-6.
3. Casali PG, Blay JY. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v198-v203.
4. Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk desmoid tumors: A multifactorial analysis of outcome. Cancer. 1999;86:2045-52.
5. Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-7. (Pubitemid 46606421)
6. Lev DC, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25:1785-91. (Pubitemid 46797962)
7. Salas S, Dufresne A, Bui B, Blay JY, Terrier P, Ranchere-Vince D, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011;29:3553-8.
8. Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, et al. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 1998;40:637-45. (Pubitemid 28104234)
9. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17:158-67. (Pubitemid 29022389)
10. Huang K, Fu H, Shi YQ, Zhou Y, Du CY. Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol. 2009;100:563-9.
11. Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, et al. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2008;34:462-8. (Pubitemid 351381296)
12. Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Péc-houx C, et al. Desmoid-type fibromatosis: a frontline conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16:2587-93.
13. Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, May-ordomo-Aranda E, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173:1518-27.